Lynda Grine

1.4k total citations · 1 hit paper
28 papers, 928 citations indexed

About

Lynda Grine is a scholar working on Immunology, Dermatology and Complementary and alternative medicine. According to data from OpenAlex, Lynda Grine has authored 28 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 11 papers in Dermatology and 5 papers in Complementary and alternative medicine. Recurrent topics in Lynda Grine's work include Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (9 papers) and Complementary and Alternative Medicine Studies (5 papers). Lynda Grine is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (9 papers) and Complementary and Alternative Medicine Studies (5 papers). Lynda Grine collaborates with scholars based in Belgium, Netherlands and France. Lynda Grine's co-authors include Chris Callewaert, Bernhard Paetzold, Britta De Pessemier, Roosmarijn E. Vandenbroucke, Claude Libert, Lien Dejager, Jo Lambert, Reinhart Speeckaert, Nanja van Geel and Mireille Van Gele and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and International Journal of Cancer.

In The Last Decade

Lynda Grine

27 papers receiving 908 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions

2021 357 citations Britta De Pessemier, Lynda Grine et al. Microorganisms profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynda Grine Belgium	13	444	443	214	116	102	28	928
Miri Kim South Korea	16	645 1.5×	312 0.7×	192 0.9×	236 2.0×	106 1.0×	65	1.3k
Marija Kaštelan Croatia	19	316 0.7×	383 0.9×	162 0.8×	87 0.8×	82 0.8×	64	898
Masakazu Takahara Japan	17	450 1.0×	258 0.6×	319 1.5×	78 0.7×	106 1.0×	55	1.2k
Slaheddine Marrakchi Tunisia	17	563 1.3×	499 1.1×	240 1.1×	192 1.7×	194 1.9×	44	1.2k
Serena Lembo Italy	22	653 1.5×	560 1.3×	166 0.8×	70 0.6×	125 1.2×	65	1.2k
Joshua Zeichner United States	20	783 1.8×	160 0.4×	167 0.8×	166 1.4×	113 1.1×	79	1.2k
Abdullateef A. Alzolibani Saudi Arabia	21	435 1.0×	185 0.4×	159 0.7×	192 1.7×	72 0.7×	57	976
Ines Brajac Croatia	18	358 0.8×	214 0.5×	141 0.7×	106 0.9×	62 0.6×	53	859
Elisa Molinelli Italy	24	605 1.4×	301 0.7×	299 1.4×	112 1.0×	62 0.6×	105	1.4k
Yong Hyun Jang South Korea	19	738 1.7×	161 0.4×	120 0.6×	151 1.3×	138 1.4×	120	1.3k

Countries citing papers authored by Lynda Grine

Since Specialization

Citations

This map shows the geographic impact of Lynda Grine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Grine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Grine more than expected).

Fields of papers citing papers by Lynda Grine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Grine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Grine. The network helps show where Lynda Grine may publish in the future.

Co-authorship network of co-authors of Lynda Grine

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Grine. A scholar is included among the top collaborators of Lynda Grine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Grine. Lynda Grine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ziyi, Laurentijn Tilleman, Filip Van Nieuwerburgh, et al.. (2024). Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis. Journal of the European Academy of Dermatology and Venereology. 38(8). 1555–1565. 3 indexed citations

Stove, Christophe P., et al.. (2022). Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice. Journal of Clinical Medicine. 11(11). 3011–3011. 8 indexed citations

Wang, Zhigang, Lynda Grine, Erwin Dreesen, et al.. (2022). Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis. Clinical and Experimental Dermatology. 47(7). 1324–1336. 6 indexed citations

Geel, Nanja van, et al.. (2022). Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties. Pigment Cell & Melanoma Research. 35(5). 480–494. 7 indexed citations

Pauwels, N., et al.. (2022). Patient-Relevant Outcomes in Psoriasis. JAMA Dermatology. 158(7). 806–806. 7 indexed citations

Pessemier, Britta De, et al.. (2021). Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms. 9(2). 353–353. 357 indexed citations breakdown →

Reek, J.M.P.A. van den, et al.. (2021). Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study. Trials. 22(1). 707–707. 15 indexed citations

Peeters, Miet, et al.. (2020). Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis. Journal of Pharmaceutical and Biomedical Analysis. 189. 113433–113433. 4 indexed citations

Grine, Lynda, et al.. (2020). Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey. Frontiers in Medicine. 7. 36–36. 5 indexed citations

10.

Grine, Lynda, et al.. (2020). Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey. Journal of Dermatological Treatment. 33(3). 1473–1481. 13 indexed citations

11.

Grine, Lynda, et al.. (2020). Comparison of Personality Traits among Patients with Psoriasis, Atopic Dermatitis, and Stress: A Pilot Study. Dermatology. 236(4). 324–328. 4 indexed citations

12.

Grine, Lynda, et al.. (2020). The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study. JMIR Research Protocols. 11(2). e26405–e26405. 7 indexed citations

13.

Grine, Lynda, et al.. (2019). A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management. Journal of the European Academy of Dermatology and Venereology. 34(4). 676–684. 27 indexed citations

14.

Geel, Nanja van, Sofie De Schepper, Lynda Grine, et al.. (2018). Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis. British Journal of Dermatology. 180(5). 1198–1205. 14 indexed citations

15.

Grine, Lynda, et al.. (2018). Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. American Journal of Clinical Dermatology. 19(5). 625–637. 10 indexed citations

16.

Grine, Lynda, Sophie Steeland, Marlies Ballegeer, et al.. (2016). Topical imiquimod yields systemic effects due to unintended oral uptake. Scientific Reports. 6(1). 20134–20134. 32 indexed citations

17.

Speeckaert, Reinhart, Jo Lambert, Lynda Grine, et al.. (2016). The many faces of interleukin-17 in inflammatory skin diseases. British Journal of Dermatology. 175(5). 892–901. 69 indexed citations

18.

Grine, Lynda, Lien Dejager, Claude Libert, & Roosmarijn E. Vandenbroucke. (2015). Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice. The Journal of Immunology. 194(11). 5094–5102. 37 indexed citations

19.

Grine, Lynda, Lien Dejager, Claude Libert, & Roosmarijn E. Vandenbroucke. (2014). An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine & Growth Factor Reviews. 26(1). 25–33. 160 indexed citations

20.

Hauwermeiren, Filip Van, Roosmarijn E. Vandenbroucke, Lynda Grine, et al.. (2014). TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction. Mucosal Immunology. 8(4). 828–840. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact